Every Form 4 that Tao Synergies Inc. (TAOX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TAOX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TAOX filings page.
TAO Synergies Inc. reported that Executive Chairman Joshua Silverman received a grant of stock options. He was awarded 200,000 options to buy common stock at an exercise price of $4.8000 per share, expiring on May 18, 2036.
All of these options will vest and become immediately exercisable after he completes one year of service following May 18, 2026, according to the filing footnote. Following this grant, he holds 200,000 stock options directly.
TAO Synergies Inc. director Bruce Bernstein received a grant of stock options to acquire 55,000 shares of common stock. The options have an exercise price of $4.80 per share and expire on May 18, 2036. All of the options vest and become exercisable after the completion of one year of service following May 18, 2026, leaving Bernstein with 55,000 stock options reported as directly owned after this grant.
TAO Synergies Inc. director William S. Singer received a grant of stock options for 35,000 shares of common stock. The options have an exercise price of $4.80 per share and expire on May 18, 2036. All options vest after one year of service following May 18, 2026.
TAO Synergies Inc. Chief Financial Officer Robert Weinstein received a grant of stock options to acquire 30,000 shares of common stock at an exercise price of $4.80 per share. According to the grant, all options vest after the completion of one year of service following May 18, 2026 and expire on May 18, 2036, leaving him with 30,000 options outstanding from this award.
TAO Synergies Inc. director Robert Ephron received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $4.80 per share and expire on May 18, 2036. Following this grant, he holds 10,000 stock options directly. According to the terms, all of these options vest and become exercisable after he completes one year of service following May 18, 2026.
TAO Synergies Inc. director William S. Singer received a grant of stock options giving him the right to buy 800 shares of common stock. The options have an exercise price of $5.52 per share and were granted at no cost.
All of these options vest and become exercisable upon completion of one year of service following April 7, 2026, and they expire on April 7, 2036. After this grant, Singer directly holds 800 stock options linked to TAO Synergies common shares.
TAO Synergies Inc. director Ephron Robert received a stock option grant for 800 shares of common stock. The option has an exercise price of $5.52 per share and expires on April 7, 2036. According to the disclosure, all 800 options will vest after the holder completes one year of service following April 7, 2026.
TAO Synergies Inc. director Bruce Bernstein received a grant of stock options covering 800 shares of common stock at an exercise price of $5.52 per share. These options were awarded at no cost and will fully vest after he completes one year of service following April 7, 2026.
TAO Synergies (TAOX) reported insider equity activity by its Chief Financial Officer, Robert Weinstein. On October 17, 2025, he received 10,000 restricted stock units that vested immediately, increasing his holdings, and the company withheld 4,000 shares at a price of $7.23 to cover taxes. Following these transactions, he beneficially owned 16,574 shares.
The filing also records an employee stock option grant for 7,000 shares at an exercise price of $10.38, exercisable starting July 14, 2026 and expiring July 14, 2035. The option grant was approved after shareholder approval on August 6, 2025.
TAO Synergies Inc. (TAOX) reported an insider equity transaction by a director on a Form 4. On October 17, 2025, the director received 15,000 restricted stock units that vested immediately under the 2020 Equity Incentive Plan.
To cover taxes upon vesting, the issuer withheld 6,000 shares at $7.23, which is not an open-market sale. Following these transactions, the director beneficially owned 19,566 shares directly.
The filing also shows an employee stock option for 7,000 shares at an exercise price of $10.38, granted effective August 6, 2025, first exercisable on July 14, 2026, and expiring on July 14, 2035. The option grant was approved by a board committee on July 14, 2025, contingent on shareholder approval of an amendment to the plan, which was obtained on August 6, 2025.
TAO Synergies (TAOX) insider filed a Form 4 reporting equity awards and related share movements. On 10/17/2025, the Executive Chairman/Director received 100,000 restricted stock units under the 2020 Equity Incentive Plan, which vested immediately. To cover taxes upon vesting, 40,000 shares were withheld by the company at a price of $7.23, a non‑open‑market transaction.
Following these transactions, the insider beneficially owns 86,681 shares. Separately, an employee stock option for 36,000 shares with an exercise price of $10.38 was reported, exercisable 07/14/2026 and expiring 07/14/2035. The option grant was approved on 07/14/2025, subject to shareholder approval of a plan amendment, which the company received on 08/06/2025.
TAO Synergies Inc. (TAOX) filed a Form 4 reporting a director’s equity award. The reporting person received an employee stock option grant for 10,000 shares at an exercise price of $10.38 per share. The options become exercisable on July 14, 2026 and expire on July 14, 2035.
The grant was approved on July 14, 2025, subject to shareholder approval of an increase to the 2020 Equity Incentive Plan; shareholders approved the amendment on August 6, 2025. Following the transaction, 10,000 derivative securities were beneficially owned on a direct basis.
TAO Synergies Inc. (TAOX) reported an insider equity award and related tax withholding. A director received 7,500 restricted stock units on October 17, 2025 that vested immediately at a stated price of $0.00 per share for reporting purposes. To cover taxes upon vesting, 3,000 shares were withheld by the issuer at $7.23 per share; this was not an open‑market sale.
Following these transactions, the insider directly owned 4,500 shares of common stock. No derivative securities were reported.
TAO Synergies Inc. (TAOX) reported director activity on a Form 4. On October 17, 2025, the reporting person received 25,000 restricted stock units that vested immediately at a stated price of $0.00. To cover taxes upon vesting, the issuer withheld 10,000 shares at a price of $7.23, noted with transaction code F (share withholding for taxes).
After these transactions, the reporting person beneficially owned 30,897 shares. Separately, an employee stock option for 12,000 shares with an exercise price of $10.38 was reported as acquired on August 6, 2025, becoming exercisable on July 14, 2026 and expiring on July 14, 2035. The option grant had been approved on July 14, 2025, subject to shareholder approval received on August 6, 2025.